Authors
Latest:
Administrative Burden of Prescribing BiologicsPrescribing biologics can require a complex approval and claims process. Creating a tiered system based on office workload can help practices understand and allocate staff time. Outsourcing approvals to pharmacies where possible can also streamline the process.
Latest:
Majority of state medical boards see increase in COVID-19 misinformation complaints against physiciansAn alarming amount of COVID-19 disinformation is prevalent even from physicians.
Latest:
Study: Lifestyle Behaviors Linked With Psoriasis DevelopmentLifestyle behaviors, such as body mass index and smoking, were shown to have a stronger association with psoriasis, regardless of genetic risk.
Latest:
Adel Haque, MD, Provides His Best Advice for New DermatologistsLearning how to prescribe biologics, talking to mentors, reviewing journals, and getting involved in clinical trials are all ways to boost your expertise.
Latest:
Burnout, Frustration Levels Continue to Grow Among PhysiciansDoctors cite more support staff, reduced patient panels among solutions.
Latest:
Diverse Perspectives in Medical Aesthetics Matter More Than EverDermatology Times® invites medical professionals in the dermatology community to speak out on the vital issues facing the specialty.
Latest:
How Can AI Improve Patient Care?AI’s ability to quickly process and interpret large quantities of health data is a valuable tool for physicians.
Latest:
Data Support the Use of First-/Second-Line Immune Checkpoint Inhibitors in HNSCCFindings from a retrospective cohort study found that immune checkpoint inhibitors induced promising responses in the first- and second-line treatment of head and neck squamous cell carcinoma.
Latest:
Dermatologist Talks About the ABCs of Wounds and HS Support at Annual MeetingExpert insights on the latest issues in wounds as well as HS resources are shared at the annual meeting.
Latest:
Study Examines Dupilumab Effectiveness in Erythrodermic Atopic DermatitisResearch published in JAMA Dermatology finds dupilumab works quickly and safely for patients with erythrodermic atopic dermatitis.
Latest:
3 Approaches to Creating a Connected Care FutureBy integrating capabilities and services, we can create health experiences that are much more than the sum of their parts.
Latest:
Severe Hemorrhage from Infantile HemangiomaA 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
Latest:
Take-home Points to Manage AcneDrs Joshua Zeichner, MD, and Mona Gohara, MD, provide take-home messages to providers treating patients with acne.
Latest:
Shingles Vaccination Counseling During the COVID-19 PandemicCDC advises not to delay shingles vaccination.
Latest:
Parents Worries About Severe Acne’s Impact on TeensMore than 90% of respondents to a recent survey expressed concern about acne’s effect on their adolescent’s mental health and social life.
Latest:
Severe Hemorrhage from Infantile HemangiomaA 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
Latest:
What You Don’t Know and Should Know About PasswordsJ.D. Norcross, director of information technology at VitalSkin Dermatology, discusses some myths and best practices with digital passwords you should know to help keep your practice information safer.
Latest:
FDA Approves Relatlimab Plus Nivolumab for Unresectable or Metastatic MelanomaThe FDA has approved the fixed-dose combination of relatlimab plus nivolumab for the treatment of adult and pediatric patients who are 12 years of age or older and who have unresectable or metastatic melanoma.
Latest:
Impacts of the Inflation Reduction Act on DoctorsHow will new federal law affect lives and wallets of physicians?
